{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:08:49Z","timestamp":1769843329548,"version":"3.49.0"},"reference-count":59,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T00:00:00Z","timestamp":1637366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1ZIAAI001102-09"],"award-info":[{"award-number":["1ZIAAI001102-09"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>A number of viruses, including Herpes Simplex Virus (HSV), West Nile Virus (WNV), La Crosse Virus (LACV), Zika virus (ZIKV) and Tick-borne encephalitis virus (TBEV), have the ability to gain access to the central nervous system (CNS) and cause severe neurological disease or death. Although encephalitis cases caused by these viruses are generally rare, there are relatively few treatment options available for patients with viral encephalitis other than palliative care. Many of these viruses directly infect neurons and can cause neuronal death. Thus, there is the need for the identification of useful therapeutic compounds that can inhibit virus replication in neurons or inhibit virus-induced neuronal cell death. In this paper, we describe the methodology to test compounds for their ability to inhibit virus-induced neuronal cell death. These protocols include the isolation and culturing of primary neurons; the culturing of neuroblastoma and neuronal stem cell lines; infection of these cells with viruses; treatment of these cells with selected drugs; measuring virus-induced cell death using MTT or XTT reagents; analysis of virus production from these cells; as well as the basic understanding in mode of action. We further show direct evidence of the effectiveness of these protocols by utilizing them to test the effectiveness of the polyphenol drug, Rottlerin, at inhibiting Zika virus infection and death of neuronal cell lines.<\/jats:p>","DOI":"10.3390\/v13112317","type":"journal-article","created":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T21:02:06Z","timestamp":1637528526000},"page":"2317","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Drug-Screening Strategies for Inhibition of Virus-Induced Neuronal Cell Death"],"prefix":"10.3390","volume":"13","author":[{"given":"Durbadal","family":"Ojha","sequence":"first","affiliation":[{"name":"Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories (RML), National Institute of Allergy and Infectious Diseases (NIAID), Hamilton, MT 59840, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyson A.","family":"Woods","sequence":"additional","affiliation":[{"name":"Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories (RML), National Institute of Allergy and Infectious Diseases (NIAID), Hamilton, MT 59840, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4177-7249","authenticated-orcid":false,"given":"Karin E.","family":"Peterson","sequence":"additional","affiliation":[{"name":"Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories (RML), National Institute of Allergy and Infectious Diseases (NIAID), Hamilton, MT 59840, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"i10","DOI":"10.1136\/jnnp.2003.034280","article-title":"Viral Encephalitis: Causes, Differential Diagnosis, and Management","volume":"7","author":"Kennedy","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1038\/s41467-021-25642-z","article-title":"OPTN is a host intrinsic restriction factor against neuroinvasive HSV-1 infection","volume":"12","author":"Ames","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-125-7-199610010-00008","article-title":"Cytomegalovirus encephalitis","volume":"125","author":"Arribas","year":"1996","journal-title":"Ann. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/08830738060210051101","article-title":"Pediatric Epstein\u2013Barr virus\u2014Associated encephalitis: 10-year review","volume":"21","author":"Doja","year":"2006","journal-title":"J. Child. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5811\/cpcem.2019.8.43010","article-title":"Varicella Zoster Virus Encephalitis","volume":"3","author":"Lizzi","year":"2019","journal-title":"Clin. Pract. Cases Emerg. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1099\/jgv.0.000780","article-title":"Human picornaviruses associated with neurological diseases and their neutralization by antibodies","volume":"98","author":"Anastasina","year":"2017","journal-title":"J. Gen. Virol."},{"key":"ref_7","unstructured":"Baron, S. (1996). Paramyxoviruses. Medical Microbiology, University of Texas Medical Branch at Galveston. [4th ed.]. Chapter 59."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/jnnp.71.4.552","article-title":"Late presentation of Nipah virus encephalitis and kinetics of the humoral immune response","volume":"71","author":"Wong","year":"2001","journal-title":"J Neurol. Neurosurg. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","article-title":"The continued threat of emerging flaviviruses","volume":"5","author":"Pierson","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Evans, A.B., and Peterson, K.E. (2019). Throw out the Map: Neuropathogenesis of the Globally Expanding California Serogroup of Orthobunyaviruses. Viruses, 11.","DOI":"10.3390\/v11090794"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Burrell, C.J., Howard, C.R., and Murphy, F.A. (2017). Chapter 35\u2014Togaviruses. Fenner and White\u2019s Medical Virology, Academic Press. [5th ed.].","DOI":"10.1016\/B978-0-12-375156-0.00035-7"},{"key":"ref_12","unstructured":"Baron, S. (1996). Rhabdoviruses: Rabies virus. Medical Microbiology, University of Texas Medical Branch at Galveston. [4th ed.]. Chapter 61."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.idc.2008.03.001","article-title":"Powassan encephalitis and Colorado tick fever","volume":"22","author":"Romero","year":"2008","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"121ps3","DOI":"10.1126\/scitranslmed.3003492","article-title":"Viral and inflammatory triggers of neurodegenerative diseases","volume":"4","author":"Deleidi","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.2741\/3595","article-title":"Virus-induced neuronal dysfunction and degeneration","volume":"14","author":"Berth","year":"2009","journal-title":"Front. Biosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.chom.2013.03.010","article-title":"Virus infections in the nervous system","volume":"13","author":"Koyuncu","year":"2013","journal-title":"Cell Host Microbe"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.tim.2015.01.002","article-title":"Axonal spread of neuroinvasive viral infections","volume":"23","author":"Taylor","year":"2015","journal-title":"Trends Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ncl.2020.09.011","article-title":"Treatment of Viral Encephalitis","volume":"39","author":"Aksamit","year":"2021","journal-title":"Neurol. Clin."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"105087","DOI":"10.1016\/j.antiviral.2021.105087","article-title":"Homoseongomycin, a compound isolated from marine actinomycete bacteria K3-1, is a potent inhibitor of encephalitic alphaviruses","volume":"191","author":"Lin","year":"2021","journal-title":"Antivir. Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Warrell, M., Warrell, D.A., and Tarantola, A. (2017). The Imperative of Palliation in the Management of Rabies Encephalomyelitis. Trop. Med. Infect. Dis., 2.","DOI":"10.3390\/tropicalmed2040052"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/2096595819896177","article-title":"Clinical features and surgical treatment of epilepsy after viral encephalitis","volume":"5","author":"Liu","year":"2019","journal-title":"Brain Sci. Adv."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/AAC.00615-10","article-title":"Resistance of herpes simplex viruses to nucleoside analogues: Mechanisms, prevalence, and management","volume":"55","author":"Piret","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1128\/AAC.47.8.2438-2441.2003","article-title":"Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir","volume":"47","author":"Lycke","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41564-021-00968-y","article-title":"Rottlerin inhibits La Crosse virus-induced encephalitis in mice and blocks release of replicating virus from the Golgi body in neuronsn","volume":"6","author":"Ojha","year":"2021","journal-title":"Nat. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.chom.2016.07.004","article-title":"A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection","volume":"20","author":"Barrows","year":"2016","journal-title":"Cell Host Microbe."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/1087057106296688","article-title":"Development and validation of a high-throughput screen for inhibitors of SARS CoV and its application in screening of a 100,000-compound library","volume":"12","author":"Severson","year":"2007","journal-title":"J. Biomol. Screen."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0166-0934(91)90008-N","article-title":"An application of tetrazolium (MTT) colorimetric assay for the screening of anti-herpes simplex virus compounds","volume":"33","author":"Takeuchi","year":"1991","journal-title":"J. Virologic. Meth."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00430-017-0493-2","article-title":"Development of a high-throughput colorimetric Zika virus infection assay","volume":"206","author":"Harms","year":"2017","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_29","first-page":"e53124","article-title":"Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds","volume":"105","author":"Tai","year":"2015","journal-title":"J. Vis. Exp."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1517\/17460441.3.6.671","article-title":"Cell-based Assays to Identify Inhibitors of Viral Disease","volume":"3","author":"Green","year":"2008","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-62703-640-5_2","article-title":"Considerations for the Use of SH-SY5Y Neuroblastoma Cells in Neurobiology","volume":"1078","author":"Kovalevich","year":"2016","journal-title":"Methods Mol. Bio."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/neu.480210209","article-title":"Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer","volume":"21","author":"Ryder","year":"1990","journal-title":"J. Neurobiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/glia.20952","article-title":"Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia","volume":"58","author":"Butchi","year":"2010","journal-title":"Glia"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Jang, Y., Shin, J.S., Lee, M.K., Jung, E., An, T., Kim, U.-I., Kim, K., and Kim, M. (2021). Comparison of Antiviral Activity of Gemcitabine with 2\u2032-Fluoro-2\u2032-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041581"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e01441-18","DOI":"10.1128\/JVI.01441-18","article-title":"Salinomycin Inhibits Influenza Virus Infection by Disrupting Endosomal Acidification and Viral Matrix Protein 2 Function","volume":"92","author":"Jang","year":"2018","journal-title":"J. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.abf1611","article-title":"SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model","volume":"371","author":"Qiao","year":"2021","journal-title":"Science"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1128\/AAC.00356-07","article-title":"In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections","volume":"51","author":"Gowen","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_38","unstructured":"Food and Drug Administration (2021, November 16). Guidance for Industry: Antiviral Product Development: Conducting and Submitting Virology Studies to the Agency, Available online: https:\/\/www.fda.gov\/ucm\/groups\/fdagov-public\/@fdagov-drugs-gen\/documents\/document\/ucm070953.pdf."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1086\/432766","article-title":"Acyclovir Sensitivity of Sequential Herpes Simplex Virus Type 2 Isolates from the Genital Mucosa of Immunocompetent Women","volume":"192","author":"Gupta","year":"2005","journal-title":"J. Infec. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12936-019-2724-z","article-title":"The past, present and future of anti-malarial medicines","volume":"18","author":"Tse","year":"2019","journal-title":"Malar. J."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Delvecchio, R., Higa, L.M., Pezzuto, P., Valad\u00e3o, A.L., Garcez, P.P., Monteiro, F.L., Loiola, E.C., Dias, A.A., Silva, F.J.M., and Aliota, M.T. (2016). Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models. Viruses, 8.","DOI":"10.1101\/051268"},{"key":"ref_42","first-page":"742936","article-title":"Rottlerin inhibits ROS formation and prevents NFkappaB activation in MCF-7 and HT-29 cells","volume":"2009","author":"Maioli","year":"2009","journal-title":"J. Biomed. Biotechnol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0304-4165(01)00203-3","article-title":"Inhibitory effects of phloroglucinol derivatives from Mallotus japonicus on nitric oxide production by a murine macrophage-like cell line, RAW 264.7, activated by lipopolysaccharide and interferon-gamma","volume":"1568","author":"Ishii","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0304-4165(02)00200-3","article-title":"Prostaglandin E(2) production and induction of prostaglandin endoperoxide synthase-2 is inhibited in a murine macrophage-like cell line, RAW 264.7, by Mallotus japonicus phloroglucinol derivatives","volume":"1571","author":"Ishii","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1128\/AEM.02151-07","article-title":"Rottlerin inhibits chlamydial intracellular growth and blocks chlamydial acquisition of sphingolipids from host cells","volume":"74","author":"Shivshankar","year":"2008","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1248\/bpb.32.631","article-title":"Potent bactericidal constituents from Mallotus philippinensis against clarithromycin and metronidazole resistant strains of Japanese and Pakistani Helicobacter pylori","volume":"32","author":"Zaidi","year":"2009","journal-title":"Biol. Pharm. Bull."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"350826","DOI":"10.1100\/2012\/350826","article-title":"Rottlerin and cancer: Novel evidence and mechanisms","volume":"2012","author":"Maioli","year":"2012","journal-title":"Sci. World J."},{"key":"ref_48","first-page":"2178","article-title":"Rottlerin exhibits anti-cancer effect through inactivation of S phase kinase-associated protein 2 in pancreatic cancer cells","volume":"6","author":"Su","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/bbrc.1994.1199","article-title":"Rottlerin, a novel protein kinase inhibitor","volume":"199","author":"Gschwendt","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20070797","article-title":"The selectivity of protein kinase inhibitors: A further update","volume":"408","author":"Bain","year":"2007","journal-title":"Biochem. J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"104621","DOI":"10.1016\/j.antiviral.2019.104621","article-title":"Virtual screening identified compounds that bind to cyclin dependent kinase 2 and prevent herpes simplex virus type 1 replication and reactivation in neurons","volume":"172","author":"Viegas","year":"2019","journal-title":"Antivir. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4103\/0976-500X.142464","article-title":"Sofosbuvir: A novel treatment option for chronic hepatitis C infection","volume":"5","author":"Bhatia","year":"2014","journal-title":"J. Pharmacol. Pharmacother."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Baz, M., and Boivin, G. (2019). Antiviral Agents in Development for Zika Virus Infections. Pharmaceuticals, 12.","DOI":"10.3390\/ph12030101"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijid.2016.12.011","article-title":"Sofosbuvir: An antiviral drug with potential efficacy against Zika infection","volume":"55","author":"Reznik","year":"2017","journal-title":"Int. J. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.antiviral.2016.11.023","article-title":"The FDA-approved drug sofosbuvir inhibits Zika virus infection","volume":"137","author":"Govero","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1128\/JVI.01492-10","article-title":"Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit Herpes Simplex virus 1 entry and cell-to-cell spread","volume":"85","author":"Lin","year":"2011","journal-title":"J. Virol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12985-018-1022-7","article-title":"In vitro antiviral activity of twenty-seven medicinal plant extracts from Southwest Nigeria against three serotypes of echoviruses","volume":"15","author":"Ogbole","year":"2018","journal-title":"Virol. J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1128\/AAC.01509-08","article-title":"Antiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn Mice","volume":"53","author":"Keyaerts","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"eabb5883","DOI":"10.1126\/scitranslmed.abb5883","article-title":"An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice","volume":"12","author":"Sheahan","year":"2020","journal-title":"Sci. Transl. Med."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/11\/2317\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:33:13Z","timestamp":1760167993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/11\/2317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,20]]},"references-count":59,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["v13112317"],"URL":"https:\/\/doi.org\/10.3390\/v13112317","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,20]]}}}